
Buy Capecitabine Online in New Zealand
Package | Dosage | Price | Price per Dose | |
---|---|---|---|---|
Dosage: 500mg | ||||
300 pill | 500mg | NZD1,783.59 | NZD5.95 | |
200 pill | 500mg | NZD1,257.00 | NZD6.29 | |
100 pill | 500mg | NZD653.97 | NZD6.54 |

Capecitabine Description
Overview of Capecitabine
Capecitabine is an oral chemotherapy drug used primarily in the treatment of various types of cancer, including colon, rectal, breast, and gastric cancers. It is designed to target and destroy cancer cells by interfering with their DNA synthesis, which inhibits their ability to divide and grow. Its ease of administration as a pill makes it a convenient option for many patients, reducing the need for frequent hospital visits compared to traditional chemotherapy.
How Capecitabine Works
The medication is a prodrug, which means it is inactive until it is metabolized inside the body. Once ingested, capecitabine is absorbed through the gastrointestinal tract and converted into 5-fluorouracil (5-FU) in the liver and tumor tissues. The active form, 5-FU, then interferes with the synthesis of DNA and RNA in cancer cells, ultimately leading to cell death. This targeted activation process helps to concentrate its effects in tumor tissues, potentially reducing damage to healthy cells.
Usage and Dosage
The specific dosage of capecitabine varies depending on the type and stage of cancer being treated, as well as individual patient factors. It is usually administered in cycles, with doses taken twice daily for a period of two weeks, followed by a rest period to allow the body to recover. Patients are advised to follow their healthcare provider’s instructions carefully, including taking the medication with or without food as prescribed and maintaining proper hydration. Regular monitoring is crucial to assess the effectiveness and manage any adverse effects.
Possible Side Effects
Like any chemotherapy drug, capecitabine can cause side effects. Common adverse reactions include nausea, vomiting, diarrhea, hand-foot syndrome (redness, swelling, and pain in the palms and soles), fatigue, and mouth sores. Some patients may experience a decrease in blood cell counts, increasing the risk of infections or bleeding. Serious but less common side effects include allergic reactions, heart problems, and severe diarrhea. Patients should report any unusual symptoms to their healthcare provider promptly.
Precautions and Interactions
Before starting capecitabine, patients should inform their doctor about any pre-existing conditions, especially liver or kidney problems, heart issues, or prior blood disorders. The medication may interact with other drugs such as warfarin, which could increase bleeding risk, or other chemotherapeutic agents. Alcohol consumption should be limited, and patients should avoid live vaccines during treatment. Regular blood tests are essential to monitor for potential toxicities and to adjust dosage if necessary.
Conclusion
Capecitabine remains a valuable option in cancer treatment due to its oral administration and targeted mechanism of action. While it offers many benefits, patients must be aware of the potential side effects and take necessary precautions. Proper medical supervision, adherence to prescribed regimens, and prompt communication about any adverse reactions can help maximize therapeutic outcomes and maintain safety during treatment.